Slider

meet the team

Dr Michael Leek

Chief Executive Officer

Angela Scott

Chief Operating Officer

Toby Rintoul

Director of Finance

Dorothy Lister

Senior Vice President - Operations

David Gallagher

Senior Vice President - IP & Legal

Tomasz Zaremba

Senior Vice President - Clinical

Slider
Dr Michael Leek
Dr Michael LeekFounder & Chief Executive
Michael has 30 years’ experience in regenerative medicine, during which he progressed 9 different cell-based products from laboratory into clinic. As co-founder, he was jointly responsible for moving Intercytex from a pre-clinical research company, to an AIM-listed biotech with several cell therapy products in the clinic. He has extensive GMP manufacture, clinical, regulatory and logistic expertise, he has directly raised over $60m in equity and grant funding.

Angela Scott
Angela ScottCo-Founder & Chief Operating Officer
Angela has 37 years in oncology research and regenerative medicine, was part of the team that cloned ‘Dolly the Sheep’, and has designed, built and commissioned several GMP manufacturing facilities. She manufactured product for the UK’s ‘first-in-man’ stem cell trial (PISCES – ReNeuron), and has held MHRA -MIA and -IMP licenses for several cell therapy products.

Toby Rintoul
Toby RintoulDirector of Finance
Toby is an experienced accountant who has worked with high growth technology companies for over 15 years. He trained in audit in London before specialising in providing financial support to entrepreneurial business. Toby has worked with a range of entities from SME’s to publicly traded companies.

Dorothy Lister
Dorothy ListerSenior Vice President - Operations
Dorothy has 32 years’ experience within contract research and manufacturing organisations and has been responsible for the project and supply chain management of large complex packaging and distribution activities in support of worldwide clinical trials for two global healthcare companies. In her previous role, Dorothy was also one of the first employees taken on to manage technical transfer for a large US CRO establishing a new European GMP testing facility in Scotland. Her operations experience has also extended to the design, build and project management of several GMP facilities and has been involved in many successful MHRA audits.

David Galagher
David GalagherCo-Founder & Senior Vice President - IP & Legal
A qualified lawyer, David has more than a decade of experience in advising companies, from SMEs to large listed companies, particularly in relation to Intellectual Property and commercialisation. David has advised start-ups, large scale manufacturing companies, Contract Research Organisations, funders and venture capitalists on a range of issues including patent protection strategy, distribution and licensing arrangements, negotiation of cross border commercial contracts, manufacturing and regulatory issues.

Tomasz Zaremba
Tomasz ZarembaSenior Vice President - Clinical
Tomasz has a PhD in Cancer Research from Newcastle University and an MBA from the University of Northampton. He has 14 years of experience in pre-clinical and clinical research and development gained in several countries (UK, Poland, France, Czech Republic) in different roles. He also has extensive experience running international phase I-IV clinical trials (ovarian, breast, thyroid, prostate and lung cancer) gained whilst at AstraZeneca. For the last two years he has been responsible for design, set-up and conduct of GDT cell therapy clinical studies. Tomasz has also been responsible for regulatory affairs at TC BioPharm and interaction with Regulatory Authorities. Tomasz has strong communication and project management skills, network of clinical collaborators and business development capabilities with major CROs.

Search